← Eichor
Study identifier: NCT06851936 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Developing a Scalable Tobacco Cessation Program for Cancer Survivors and Caregivers

Condition: Nicotine Use · Tobacco Use  ·  Sponsor: University of Florida

PhaseNA
Planned participants204
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersYes

About this study

Given the challenges to delivering tobacco cessation treatment in oncology care and the unique challenges faced by individuals attempting to quit tobacco after a cancer diagnosis, scalable cessation programs that are tailored to the experiences of cancer survivors that also integrate caregiver/family support are needed. To address this need, this study will use an intervention that consists of two primary strategies: 1) a tailored cessation program for cancer survivors and family members/caregivers who use tobacco and 2) healthcare provider training. Healthcare providers will receive training on the AAC model (Ask patients about tobacco use, Advise patients to quit, Connect patients to cessation resources), including materials focused on tobacco cessation in cancer care from the CDC, as well as a brief evidence-based communication skills training based on the C-LEAR (Counsel, Listen, Empathize, Answer, Recommend) approach.

This description comes directly from the study's public registry record.

Talk to the study team

Erika Barahona, M. Ed  ·  352-273-7345  ·  ebarahona@ufl.edu

Always discuss trial participation with your own doctor first.

Locations (1)

University of FloridaGainesville, Florida, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06851936